This inventor holds 8 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Novartis Ag, Novartis Pharma Ag. Active years: 2023-2026.
Company Filing History:
Years Active: 2023-2026
Title: Kathrin Serno-Schersch: Innovator in Pharmaceutical Products
Introduction
Kathrin Serno-Schersch is a notable inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments for autoimmune disorders. With a total of 8 patents to her name, her work is recognized for its impact on medical science.
Latest Patents
Her latest patents focus on pharmaceutical products and stable liquid compositions of IL-17 antibodies. These patents include the development of AIN457 (secukinumab) and detail processes for creating these pharmaceutical products and compositions. The disclosures also emphasize the use of these products for treating various IL-17-mediated disorders, such as psoriasis, ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis.
Career Highlights
Kathrin currently works at Novartis AG, a leading global healthcare company. Her role involves extensive research and development in the pharmaceutical sector, where she applies her expertise to create effective treatments for patients.
Collaborations
One of her notable collaborators is Susanne Joerg, who works alongside her in advancing their shared goals in pharmaceutical innovation.
Conclusion
Kathrin Serno-Schersch's contributions to the field of pharmaceuticals highlight her dedication to improving healthcare through innovative solutions. Her work continues to pave the way for advancements in the treatment of autoimmune disorders.